Developing a surveillance system for HIV pre-exposure prophylaxis (PrEP) use in pregnancy in Malawi
{{output}}
Background: Pregnant and breastfeeding women are at elevated risk of HIV acquisition. The World Health Organization (WHO) recommends use of oral TDF/FTC and long-acting injectables cabotegravir (CAB-LA) and lenacapavir (LEN) for ... ...
